Handelsbanken Fonder
USNA icon

Handelsbanken Fonder’s Usana Health Sciences USNA Stock Holding History

Handelsbanken Fonder’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,000
Closed -$217K – 1601
2022
Q2 		$217K Sell
3,000
-800
-21% -$59.6K ﹤0.01% 1475
2022
Q1 		$302K Hold
3,800
– – ﹤0.01% 1514
2021
Q4 		$385K Hold
3,800
– – ﹤0.01% 1514
2021
Q3 		$350K Hold
3,800
– – ﹤0.01% 1543
2021
Q2 		$389K Buy
+3,800
New +$382K ﹤0.01% 1542

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Handelsbanken Fonder's USNA Position: Q3 2022 in Review

Handelsbanken Fonder sold out of Usana Health Sciences (USNA) in Q3 2022, closing a stake of 3,000 shares — an estimated $217K sold.

Handelsbanken Fonder first reported a position in USNA in Q2 2021 and held it in 5 quarters. The position peaked at $389K in Q2 2021. 172 funds tracked by Wall St. Rank hold USNA as of Q3 2022.

  • Handelsbanken Fonder reported no remaining Usana Health Sciences position as of Q3 2022 after selling out during the quarter.
  • Handelsbanken Fonder sold 3,000 Usana Health Sciences shares in Q3 2022, an estimated $217K.
  • Handelsbanken Fonder first reported a position in Usana Health Sciences in Q2 2021 and held it in 5 quarters.
  • Handelsbanken Fonder's Usana Health Sciences position peaked at $389K in Q2 2021.
  • 172 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2022.

Based on Handelsbanken Fonder's 13F filing for Q3 2022, filed 27 Oct 2022.